Jacob J. Hoenig

Mr. Jacob J. Hoenig

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2026 in Nanomaterials
Verified
Journal Article
Open access
PDF file
YPYu Ping
Yu Ping
LCLydia Chen
Lydia Chen
JHJacob J. Hoenig
Jacob J. Hoenig
XYXiaohan Yang
Xiaohan Yang
FCFanny Chapelin
Fanny Chapelin
Adoptive cell therapies, and more specifically, regulatory T cell (Treg) therapies, have shown significant therapeutic promise across multiple immune-mediated diseases including graft-versus-host disease (GvHD), solid organ transplant (SOT) rejection, and autoimmune diseases. One key challenge is the lack of insight into the biodistribution and fate of adoptively transferred T cells and Tregs in living organisms. These uncertainties delay progress on establishing optimal dosage(s), infusion timing and route, as well as investigations into off-target effects. Magnetic resonance imaging (MRI) cell tracking is particularly beneficial in this setting because it enables real-time, deep-tissue coverage without ionizing radiation. In this review, we compare existing MRI T cell tracking strategies using iron oxide particles and fluorinated agents. We describe preclinical and clinical applications of MRI for cell therapy tracking and provide a perspective on the potential impact on the field.

6 August 2026 in ACS Nano
Verified
Journal Article
Closed access
NKNishta Krishnan
Nishta Krishnan
AMAnimesh Mohapatra
Animesh Mohapatra
ELEmily Lam
Emily Lam
EWElizabeth L. Wilkinson
Elizabeth L. Wilkinson
FUFederico Urbano-Munoz
Federico Urbano-Munoz
LZLiangfang Zhang
Liangfang Zhang